Previous Article | Next Article 
Journal of Virology, May 1999, p. 4447-4451, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Type 1 CD4+ T-Cell Help Is Required for Induction of
Antipeptide Multispecific Cytotoxic T Lymphocytes by a Lipopeptidic
Vaccine in Rhesus Macaques
Lorenzo
Mortara,1,*
Helene
Gras-Masse,2
Corinne
Rommens,2
Alain
Venet,1
Jean-Gerard
Guillet,1 and
Isabelle
Bourgault-Villada1
Institut Cochin de Génétique
Moléculaire (ICGM), Laboratoire d'Immunologie des Pathologies
Infectieuses et Tumorales, INSERM U445
Université René
Descartes, Hôpital Cochin, 75014 Paris,1
and Laboratoire Synthèse, Structure et Fonction des
Biomolécules, URA CNRS 1309, Institut de Biologie de
Lille
Université de Lille II, Institut Pasteur de Lille, 59021 Lille Cedex,2 France
Received 26 June 1998/Accepted 21 January 1999
We have optimized the induction of antiviral cytotoxic T
lymphocytes (CTL) in rhesus macaques by a lipopeptide
vaccine containing seven peptides from simian immunodeficiency virus
(SIV) Nef and Gag proteins and a strong T-helper peptide from tetanus
toxoid (TT) that is promiscuous in humans (peptide TT 830-846). Two of the eight immunized macaques showed T-helper (Th) cell proliferation and a specific synthesis of gamma interferon in response to TT 830-846 peptide. They also showed multispecific cytotoxic activity against
three to five of the immunizing SIV peptides. These results show the
importance of a strong specific type 1 Th response for inducing a
multispecific CTL response in vivo, which is essential for the
development of an anti-human immunodeficiency virus vaccine.
*
Corresponding author. Mailing address: ICGM, INSERM
U445, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. Phone:
(33) 01 44 07 18 21. Fax: (33) 01 44 07 14 25. E-mail:
mortara{at}cochin.inserm.fr.
Journal of Virology, May 1999, p. 4447-4451, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Slingluff, C. L. Jr, Petroni, G. R., Olson, W., Czarkowski, A., Grosh, W. W., Smolkin, M., Chianese-Bullock, K. A., Neese, P. Y., Deacon, D. H., Nail, C., Merrill, P., Fink, R., Patterson, J. W., Rehm, P. K.
(2008). Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens. JCO
26: 4973-4980
[Abstract]
[Full Text]
-
Azizi, A., Anderson, D. E., Torres, J. V., Ogrel, A., Ghorbani, M., Soare, C., Sandstrom, P., Fournier, J., Diaz-Mitoma, F.
(2008). Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques. J. Immunol.
180: 2174-2186
[Abstract]
[Full Text]
-
Villada, I. B., Barracco, M. M., Ziol, M., Chaboissier, A., Barget, N., Berville, S., Paniel, B., Jullian, E., Clerici, T., Maillere, B., Guillet, J. G.
(2004). Spontaneous Regression of Grade 3 Vulvar Intraepithelial Neoplasia Associated with Human Papillomavirus-16-Specific CD4+ and CD8+ T-Cell Responses. Cancer Res.
64: 8761-8766
[Abstract]
[Full Text]
-
Gahery-Segard, H., Pialoux, G., Figueiredo, S., Igea, C., Surenaud, M., Gaston, J., Gras-Masse, H., Levy, J.-P., Guillet, J.-G.
(2003). Long-Term Specific Immune Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine: Characterization of CD8+-T-Cell Epitopes Recognized. J. Virol.
77: 11220-11231
[Abstract]
[Full Text]
-
Daftarian, P., Ali, S., Sharan, R., Lacey, S. F., La Rosa, C., Longmate, J., Buck, C., Siliciano, R. F., Diamond, D. J.
(2003). Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge. J. Immunol.
171: 4028-4039
[Abstract]
[Full Text]
-
Andrieu, M., Desoutter, J.-F., Loing, E., Gaston, J., Hanau, D., Guillet, J.-G., Hosmalin, A.
(2002). Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells. J. Virol.
77: 1564-1570
[Abstract]
[Full Text]
-
Katae, M., Miyahira, Y., Takeda, K., Matsuda, H., Yagita, H., Okumura, K., Takeuchi, T., Kamiyama, T., Ohwada, A., Fukuchi, Y., Aoki, T.
(2002). Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy. Infect. Immun.
70: 4833-4840
[Abstract]
[Full Text]
-
Vogel, T. U., Beer, B. E., zur Megede, J., Ihlenfeldt, H.-G., Jung, G., Holzammer, S., Watkins, D. I., Altman, J. D., Kurth, R., Norley, S.
(2002). Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge. J. Gen. Virol.
83: 81-91
[Abstract]
[Full Text]
-
Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S.-S., Choppin, J., Gahery-Segard, H., Boulanger, P., Guillet, J.-G.
(2002). Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response. J. Virol.
76: 127-135
[Abstract]
[Full Text]
-
Gahéry-Ségard, H., Pialoux, G., Charmeteau, B., Sermet, S., Poncelet, H., Raux, M., Tartar, A., Lévy, J.-P., Gras-Masse, H., Guillet, J.-G.
(2000). Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine. J. Virol.
74: 1694-1703
[Abstract]
[Full Text]